Theranostics, 2026
Metabolic-Immune Reprogramming via CuZnS@BSA Nanoregulators to Overcome Resistance in Triple-Negative Breast Cancer

Yang J., Li Q., Zhao P. et al.

BMC Cancer, 2026
Sleep patterns and breast cancer risk: a prospective cohort study integrating multi-omics and machine learning

Chang X., Zuo S., Wang Z. et al.

European Journal of Preventive Cardiology, 2026
Women with angina and no obstructive coronary artery disease: IL-6 identifies a cardiometabolic high-risk phenotype and predicts cardiovascular events

Haahr R., Rytoft L., Mygind N. et al.

Nature Medicine, 2026
Longitudinal plasma proteomics predict phenoconversion to clinically manifest ALS

Ran X., Wuu J., Qin Z. et al.

Cardiovascular Diabetology, 2026
Proteomic signatures characterized by inflammatory signaling and metabolic processes have divergent associations with 30-year incidence of coronary artery disease in type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications cohort

Zhou J., Mychaleckyj J., Haddad F. et al.

Aging Cell, 2026
Construction and Validation of Plasma Protein‐Based Musculoskeletal Biological Age and Genetic and Environmental Risk Profiles

Zhong Y., Xia M., Zhao X. et al.

Journal of Colloid and Interface Science, 2026
Introduction of optimized folate group modification on lipid-coated magnetic nanobeads enables targeting of folate receptor beta

Schaaf M., Offer S., Zhang H. et al.

npj Genomic Medicine, 2026
Circulating cell-free RNA signatures associate with plaque calcification in advanced carotid atherosclerosis

Wei J., Lan T., Zhu Y. et al.

Neurological Sciences, 2026
Proteome-wide Mendelian randomization identifies causal plasma proteins in frontotemporal dementia

Yao Y., Zou Q., Chen K.

International Journal of Cardiology, 2026
Activation of the complement lectin pathway is associated with long-term cardiac dysfunction and incident heart failure in acute coronary syndrome patients

Zhong B., King B., Mares R. et al.

Communications Biology, 2026
BMI-driven multi-omics analysis profiles the molecular mechanism of psycho-metabolic nexus and contributes to risk stratification

Guo X., Feng Y., Huang P. et al.

Allergy, 2026
Distinct Immunometabolic Profiles in Finnish and Russian Karelian Adolescents With Contrasting Allergy Risk

Fyhrquist N., Riskumäki M., Karisola P. et al.

Proteomes, 2026
Proteomic Mediators Linking Autoimmune Diseases to Major Adverse Cardiovascular Events: Insights from the UK Biobank

Huang J., Liu C., Sperling L. et al.

Nature Genetics, 2026
Nanoparticle-enriched mass spectrometry proteomics in British South Asians identifies links between genetic variants, plasma protein levels and disease risk

Pietzner M., Williamson A., Hunt K. et al.

Diabetes, Obesity and Metabolism, 2026
Large‐Scale Plasma Proteomics Enhances Prediction of Liver‐Related Events Among Individuals With Prediabetes and Type 2 Diabetes: A Prospective Cohort Study in the UK Biobank

Ye C., Zhang Z., Ding Y. et al.

Immunity & Ageing, 2026
Reduced NK cell frequency in older patients with evolving fractures is linked to a distinct inflammatory cytokine profile

Moch J., Kappes J., Jauregui R. et al.

Annals of the Rheumatic Diseases, 2026
CNS immune remodelling in SLE associated with anti-CD19 CAR-T therapy

Sun J., Hu X., Li W. et al.

Nature Communications, 2026
Absent pleocytosis in infant viral central nervous system infections reflects lymphocyte depletion and cytokine activation

Mills C., Drummond H., Groves H. et al.

Brain, Behavior, & Immunity - Health, 2026
Plasma proteomic profile of inflammatory depressive symptoms

Ängeby F., Ventorp F., Stiernborg M. et al.

Brain, Behavior, & Immunity - Health, 2026
Plasma proteomic profile of inflammatory depressive symptoms

Ängeby F., Ventorp F., Stiernborg M. et al.